Clinical Trial Update: Glivec in Pediatric Chronic Myeloid Leukemia (CML) [Phase 4]

View source ↗

Summary

This clinical trial update notes the Phase 4 study of imatinib (Glivec) for pediatric chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Glivec (imatinib)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Chronic Myeloid Leukemia | Phase 4 | Status: COMPLETED